Landos Biopharma, Inc. announced that Gregory Oakes has been named President and has been appointed to the Landos Board of Directors, effective immediately. Tim M. Mayleben, who has been serving as interim President and Chief Executive Officer since November 2021, will continue to serve as a member of the Company's Board of Directors.Mr. Oakes is an accomplished pharmaceutical industry executive bringing more than 25 years of experience to Landos. He most recently served as President, North America, Executive Vice President and member of the Executive Committee of Vifor Pharma and previously held leadership roles at Amgen, Celgene Corporation, Novartis International AG and Schering- Plough (Merck).

He brings deep expertise in supporting development stage programs, from optimizing clinical strategy and competitive positioning to achieving successful commercialization. He also has extensive experience in pricing, access and reimbursement, strategic partnerships and driving profitability for small, mid-sized and large pharmaceutical companies.